Genenta Science S.p.A. (GNTA)
NASDAQ: GNTA · Real-Time Price · USD
5.10
-0.35 (-6.42%)
Oct 31, 2024, 4:00 PM EDT - Market closed

Genenta Science Income Statement

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Selling, General & Admin
4.865.265.712.30.90.92
Research & Development
4.596.475.343.394.693.7
Operating Expenses
9.4511.7311.045.695.594.62
Operating Income
-9.45-11.73-11.04-5.69-5.59-4.62
Interest Expense
----0.01-0.01-0.01
Interest & Investment Income
0.310.310.04---
Currency Exchange Gain (Loss)
0.09-0.222.29---
Other Non Operating Income (Expenses)
0.13-00.240.020.010.04
EBT Excluding Unusual Items
-8.92-11.65-8.48-5.68-5.59-4.6
Other Unusual Items
---0.15--
Pretax Income
-8.92-11.65-8.48-5.53-5.59-4.6
Net Income
-8.92-11.65-8.48-5.53-5.59-4.6
Net Income to Common
-8.92-11.65-8.48-5.53-5.59-4.6
Shares Outstanding (Basic)
181818151513
Shares Outstanding (Diluted)
181818151513
Shares Change (YoY)
0.11%0.00%20.77%3.74%14.93%-
EPS (Basic)
-0.49-0.64-0.47-0.37-0.38-0.36
EPS (Diluted)
-0.49-0.64-0.47-0.37-0.38-0.36
Free Cash Flow
-5.69-11.22-7.45-6.97-6.07-2.49
Free Cash Flow Per Share
-0.31-0.62-0.41-0.46-0.42-0.20
EBITDA
-9.41-11.69-11.04-5.68-5.59-
D&A For EBITDA
0.040.040.0100-
EBIT
-9.45-11.73-11.04-5.69-5.59-4.62
Source: S&P Capital IQ. Standard template. Financial Sources.